Additionally, immunohistochemistry (IHC) of matched tumour cores and predominantly non-tumorous margins of three patients confirmed increased BCL-xL and MCL-1 expression within the tumour cores compared to the margins (Fig. 1G; Supplementary Fig. 1C). The gene discussed is BCL2L1; the disease is neoplasm.